<VariationArchive VariationID="1071222" VariationName="NM_001379200.1(TBX1):c.1117del (p.Leu373fs)" VariationType="Deletion" Accession="VCV001071222" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064941" VariationID="1071222">
      <GeneList>
        <Gene Symbol="TBX1" FullName="T-box transcription factor 1" GeneID="6899" HGNC_ID="HGNC:11592" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="19756703" stop="19783593" display_start="19756703" display_stop="19783593" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="19744225" stop="19771115" display_start="19744225" display_stop="19771115" Strand="+" />
          </Location>
          <OMIM>602054</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX1">Some evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001379200.1(TBX1):c.1117del (p.Leu373fs)</Name>
      <CanonicalSPDI>NC_000022.11:19766468:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="19766469" stop="19766469" display_start="19766469" display_stop="19766469" variantLength="1" positionVCF="19766468" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="19753992" stop="19753992" display_start="19753992" display_stop="19753992" variantLength="1" positionVCF="19753991" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>L364fs</ProteinChange>
      <ProteinChange>L373fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_226" sequenceAccession="LRG_226">
            <Expression>LRG_226:g.14767del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_226t1" sequenceAccession="LRG_226t1">
            <Expression>LRG_226t1:c.1090del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_226p1" sequenceAccession="LRG_226p1" change="p.Leu364fs">
            <Expression>LRG_226p1:p.Leu364fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.19753992del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.19753992del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.19766469del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.19766469del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009229.1" sequenceAccession="NG_009229" sequenceVersion="1" change="g.14767del">
            <Expression>NG_009229.1:g.14767del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379200.1" sequenceAccession="NM_001379200" sequenceVersion="1" change="c.1117del" MANESelect="true">
            <Expression>NM_001379200.1:c.1117del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366129.1" sequenceAccession="NP_001366129" sequenceVersion="1" change="p.Leu373fs">
            <Expression>NP_001366129.1:p.Leu373fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080647.1" sequenceAccession="NM_080647" sequenceVersion="1" change="c.1090del">
            <Expression>NM_080647.1:c.1090del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_542378.1" sequenceAccession="NP_542378" sequenceVersion="1" change="p.Leu364fs">
            <Expression>NP_542378.1:p.Leu364fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005992.1" sequenceAccession="NM_005992" sequenceVersion="1" change="c.1009+467del">
            <Expression>NM_005992.1:c.1009+467del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_080646.2" sequenceAccession="NM_080646" sequenceVersion="2" change="c.1009+467del">
            <Expression>NM_080646.2:c.1009+467del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2145838229" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001379200.1(TBX1):c.1117del (p.Leu373fs) AND DiGeorge syndrome" Accession="RCV001383639" Version="6">
        <ClassifiedConditionList TraitSetID="2059">
          <ClassifiedCondition DB="MedGen" ID="C0012236">DiGeorge syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-03-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14585638</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15703190</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2059" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4960" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">DiGeorge syndrome</ElementValue>
                <XRef ID="MONDO:0008564" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypoplasia of thymus and parathyroid</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Third and fourth pharyngeal pouch syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DiGeorge anomaly</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DiGeorge sequence</ElementValue>
                <XRef ID="22q11.2+Deletion+Syndrome/20" DB="Genetic Alliance" />
                <XRef ID="Sedlackova+syndrome/6482" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial third and fourth pharyngeal pouch syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pharyngeal pouch syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thymic aplasia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Catch22</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DGS</ElementValue>
                <XRef Type="MIM" ID="188400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15118" />
                <XRef ID="15118" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with 22q11.2 deletion syndrome (22q11.2DS) can present with a wide range of features that are highly variable, even within families. The major clinical manifestations of 22q11.2DS include congenital heart disease, particularly conotruncal malformations (ventricular septal defect, tetralogy of Fallot, interrupted aortic arch, and truncus arteriosus), palatal abnormalities (velopharyngeal incompetence, submucosal cleft palate, bifid uvula, and cleft palate), immune deficiency, characteristic facial features, and learning difficulties. Hearing loss can be sensorineural and/or conductive. Laryngotracheoesophageal, gastrointestinal, ophthalmologic, central nervous system, skeletal, and genitourinary anomalies also occur. Psychiatric illness and autoimmune disorders are more common in individuals with 22q11.2DS.</Attribute>
                <XRef ID="NBK1523" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301696</ID>
                <ID Source="BookShelf">NBK1523</ID>
              </Citation>
              <Citation Type="general" Abbrev="Int'l 22q11.2 Del Syndrome Consortium, 2011">
                <ID Source="pmc">3197829</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987430</ID>
              </Citation>
              <Citation Type="general">
                <ID Source="PubMed">11195019</ID>
              </Citation>
              <Citation Type="general" Abbrev="Fung et. al., 2015">
                <ID Source="PubMed">25569435</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27467454</ID>
              </Citation>
              <XRef ID="567" DB="Orphanet" />
              <XRef ID="C0012236" DB="MedGen" />
              <XRef ID="MONDO:0008564" DB="MONDO" />
              <XRef Type="MIM" ID="188400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3108491" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10112336|MedGen:C0012236" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582859" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14585638</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15703190</ID>
          </Citation>
          <Comment>This variant disrupts the C-terminus of the TBX1 protein. Other variant(s) that disrupt this region (p.Ser408Trpfs*52) have been determined to be pathogenic (PMID: 14585638, 15703190). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with TBX1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change results in a premature translational stop signal in the TBX1 gene (p.Leu364Cysfs*6). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 132 amino acids of the TBX1 protein. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.19753992del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0012236" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3108491" TraitType="Disease" MappingType="XRef" MappingValue="C0012236" MappingRef="MedGen">
        <MedGen CUI="C0012236" Name="DiGeorge syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

